Literature DB >> 25448226

Reviewing and reconsidering invasion assays in head and neck cancer.

Ronald C Inglehart1, Christina S Scanlon1, Nisha J D'Silva2.   

Abstract

Head and neck squamous cell carcinomas (HNSCC) are malignant tumors that arise from the surface epithelium of the oral cavity, oropharynx and larynx, primarily due to exposure to chemical carcinogens or the human papilloma virus. Due to their location, dental practitioners are well-positioned to detect the lesions. Deadlier than lymphoma or melanoma, HNSCC is incompletely understood. For these reasons, dental practitioners and researchers are focused on understanding HNSCC and the processes driving it. One of these critical processes is invasion, the degradation of the basement membrane by HNSCC cells with subsequent movement into the underlying connective tissue, blood vessels or nerves. Cancer cells metastasize to distant sites via the blood vessels, lymphatics and nerves. Metastasis is associated with poor survival. Since invasion is essential for development and metastasis of HNSCC, it is essential to understand the mechanism(s) driving this process. Elucidation of the mechanisms involved will facilitate the development of targeted treatment, thereby accelerating development of precision/personalized medicine to treat HNSCC. Robust in vitro and in vivo assays are required to investigate the mechanistic basis of invasion. This review will focus on in vitro and in vivo assays used to study invasion in HNSCC, with special emphasis on some of the latest assays to study HNSCC.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HNSCC; In vitro; In vivo; Invasion; Squamous cell carcinoma

Mesh:

Year:  2014        PMID: 25448226      PMCID: PMC4254578          DOI: 10.1016/j.oraloncology.2014.09.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  61 in total

Review 1.  Animal models in oral cancer research.

Authors:  B Mognetti; F Di Carlo; G N Berta
Journal:  Oral Oncol       Date:  2005-11-02       Impact factor: 5.337

2.  Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis.

Authors:  Sourabh Ghosh; Manjunath B Joshi; Danila Ivanov; Chantal Feder-Mengus; Giulio C Spagnoli; Ivan Martin; Paul Erne; Therese J Resink
Journal:  FEBS Lett       Date:  2007-08-28       Impact factor: 4.124

Review 3.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

Review 4.  Engineering skin to study human disease--tissue models for cancer biology and wound repair.

Authors:  Jonathan A Garlick
Journal:  Adv Biochem Eng Biotechnol       Date:  2007       Impact factor: 2.635

5.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.

Authors:  Cedric Gaggioli; Steven Hooper; Cristina Hidalgo-Carcedo; Robert Grosse; John F Marshall; Kevin Harrington; Erik Sahai
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

Review 6.  Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma.

Authors:  Jarrett E Walsh; Deanne M R Lathers; Angela C Chi; M Boyd Gillespie; Terry A Day; M Rita I Young
Journal:  Curr Treat Options Oncol       Date:  2007-06

7.  The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.

Authors:  R Banerjee; R-S Mani; N Russo; C S Scanlon; A Tsodikov; X Jing; Q Cao; N Palanisamy; T Metwally; R C Inglehart; S Tomlins; C Bradford; T Carey; G Wolf; S Kalyana-Sundaram; A M Chinnaiyan; S Varambally; N J D'Silva
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

8.  Chemotaxis of cell populations through confined spaces at single-cell resolution.

Authors:  Ziqiu Tong; Eric M Balzer; Matthew R Dallas; Wei-Chien Hung; Kathleen J Stebe; Konstantinos Konstantopoulos
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

9.  Lymphocyte migration into three-dimensional collagen matrices: a quantitative study.

Authors:  S L Schor; T D Allen; B Winn
Journal:  J Cell Biol       Date:  1983-04       Impact factor: 10.539

10.  A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro.

Authors:  Yoonseok Kam; Cherise Guess; Lourdes Estrada; Brandy Weidow; Vito Quaranta
Journal:  BMC Cancer       Date:  2008-07-14       Impact factor: 4.430

View more
  10 in total

Review 1.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.

Authors:  Logan C DeBord; Ravi R Pathak; Mariana Villaneuva; Hsuan-Chen Liu; Daniel A Harrington; Wendong Yu; Michael T Lewis; Andrew G Sikora
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck.

Authors:  Zhongti Zhang; Fayu Liu; Zhenning Li; Dan Wang; Ruiwu Li; Changfu Sun
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

Review 3.  Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.

Authors:  Christopher Montemagno; Frédéric Luciano; Gilles Pagès
Journal:  Methods Mol Biol       Date:  2022

4.  Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.

Authors:  Xiao Jiang; Juan Wang; Xijuan Chen; Yun Hong; Tong Wu; Xiaobing Chen; Juan Xia; Bin Cheng
Journal:  Oncotarget       Date:  2016-03-29

5.  Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.

Authors:  Yordan Benhamou; Vincent Picco; Hélène Raybaud; Anne Sudaka; Emmanuel Chamorey; Sanja Brolih; Martino Monteverde; Marco Merlano; Cristiana Lo Nigro; Damien Ambrosetti; Gilles Pagès
Journal:  Oncotarget       Date:  2016-07-12

6.  Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.

Authors:  Hongfei Wang; Xueyi Liang; Mianxiang Li; Xiaoan Tao; Shanshan Tai; Zhaona Fan; Zhi Wang; Bin Cheng; Juan Xia
Journal:  Cancer Sci       Date:  2017-07-18       Impact factor: 6.716

7.  R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.

Authors:  Liping Zhang; Yan Song; Zihang Ling; Yuanyuan Li; Xianyue Ren; Jing Yang; Zhi Wang; Juan Xia; Weizhen Zhang; Bin Cheng
Journal:  EBioMedicine       Date:  2019-05-13       Impact factor: 8.143

8.  Upregulated miR‑411‑5p levels promote lymph node metastasis by targeting RYBP in head and neck squamous cell carcinoma.

Authors:  Chi Zhang; Hongfei Wang; Miao Deng; Lihong He; Fan Ping; Yuan He; Zhaona Fan; Bin Cheng; Juan Xia
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

9.  The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.

Authors:  Anais Hagege; Damien Ambrosetti; Julien Boyer; Alexandre Bozec; Jérôme Doyen; Emmanuel Chamorey; Xingkang He; Isabelle Bourget; Julie Rousset; Esma Saada; Olivia Rastoin; Julien Parola; Frederic Luciano; Yihai Cao; Gilles Pagès; Maeva Dufies
Journal:  Theranostics       Date:  2021-09-21       Impact factor: 11.556

Review 10.  Organotypic three-dimensional assays based on human leiomyoma-derived matrices.

Authors:  Tuula Salo; Mauricio Rocha Dourado; Elias Sundquist; Ehsanul Hoque Apu; Ilkka Alahuhta; Katja Tuomainen; Jenni Vasara; Ahmed Al-Samadi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.